Actinium reports ATNM-400 cancer therapy data at AACR meeting
Go back to Actinium reports ATNM-400 cancer therapy data at AACR meeting| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.13 +0.05 (4.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.08 | 52 Week High | $3.50 | |||
| Open | $1.09 | 52 Week Low | $0.86 | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $-7.61 | |||
| Volume | 183,388 | |||||
